# Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria

> **NCT03819647** · PHASE2 · COMPLETED · sponsor: **Biocodex** · enrollment: 15 (actual)

## Conditions studied

- Primary Hyperoxaluria

## Interventions

- **DRUG:** stiripentol (Diacomit)

## Key facts

- **NCT ID:** NCT03819647
- **Lead sponsor:** Biocodex
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-21
- **Primary completion:** 2020-12-18
- **Final completion:** 2021-03-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2021-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03819647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03819647, "Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03819647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*